Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03109314Phase 4Completed
Phase 4, randomised, open-label trial of donepezil in amblyopia (2 arms). Primary endpoints: Improvement in percent-correct performance in the respective training task, Visual acuity and 2 more. Started May 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03109314.